Glycogen Synthase Kinase 3 Beta - Pipeline Review, H1 2020

Published	Pages	Publisher	Report code
May 2020	69	Global Markets Direct	ASDR-534934

Published: May 2020 - Pages : 69 - Publisher : Global Markets Direct - Report code : ASDR-534934

Actuate Therapeutics Inc
Alzamend Neuro Inc
AMO Pharma Ltd
Angelini Group
Ankar Pharma SL
Avenzoar Pharmaceuticals Inc
CerebraMed
Collaborative Medicinal Development LLC
InnoBioscience LLC
Novosteo Inc
Park Active Molecules
Zovis Pharmaceuticals

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

This report can be of interest as well:

Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) Drugs in...

Published: September, 2022 | Report code: ASDR-610436